Skip to main content

Table 2 Levels of lipids and CRP among different APOE genotype carriers

From: Interactive effects of C-reactive protein levels on the association between APOE variants and triglyceride levels in a Taiwanese population

APOE SNP

MM

Mm

mm

β (95 % CI)

P valuea

MM

Mm + mm

β (95 % CI)

P valuea

rs429358

TT (n = 480)

CT (n = 96)

CC (n = 8)

  

TT (n = 480)

CT + CC (n = 104)

  

T-cholesterol (mg/dL)

197.1 ± 35.9

204.2 ± 40.1

210.9 ± 28.2

6.67 (−0.13–13.46)

0.054

197.1 ± 35.9

204.7 ± 39.3

7.03 (−0.56–14.63)

0.069

LDL-C (mg/dL)

114.5 ± 32.4

121.0 ± 35.7

132.1 ± 23.0

7.02 (0.90–13.14)

0.025

114.5 ± 32.4

121.8 ± 34.9

7.06 (0.22–13.91)

0.043

HDL-C (mg/dL)

55.8 ± 14.7

52.3 ± 12.1

51.3 ± 13.3

−0.29 (−0.038 to −0.001)

0.040

55.8 ± 14.7

52.2 ± 12.1

−0.02 (−0.04–0.001)

0.063

Triglyceride (mg/dL)

138.3 ± 119.9

165.1 ± 122.7

138.0 ± 68.5

0.047 (0.004–0.09)

0.034

138.3 ± 119.9

163.0 ± 119.4

0.055 (0.006–0.103)

0.027

CRP (mg/L)

1.12 ± 1.40

0.79 ± 1.19

1.96 ± 1.99

−0.12 (−0.21 to −0.04)

0.005

1.12 ± 1.40

0.88 ± 1.29

−0.17 (−0.27 to −0.08)

3.8 x 10−4

rs7412

CC (n = 496)

CT (n = 84)

TT (n = 5)

  

CC (n = 496)

CT + TT (n = 89)

  

T-cholesterol (mg/dL)

201.0 ± 35.5

184.3 ± 37.9

169.8 ± 65.8

−15.77 (−23.13 to −8.40)

3.01 x 10−5

201.0 ± 35.5

183.5 ± 39.5

−17.08 (−25.08–9.08)

3.2 x 10−5

LDL-C (mg/dL)

118.9 ± 32.1

100.2 ± 31.8

65.0 ± 21.4

−19.82 (−26.36 to −13.28)

4.55 x 10−9

118.9 ± 32.1

98.3 ± 32.3

−20.36 (−27.49–13.24)

3.1 x 10−8

HDL-C (mg/dL)

54.7 ± 14.2

57.8 ± 15.3

50.4 ± 8.5

0.01 (−0.007–0.34)

0.188

54.7 ± 14.2

57.4 ± 15.0

0.02 (−0.005–0.04)

0.129

Triglyceride (mg/dL)

143.6 ± 121.1

133.2 ± 108.9

217.8 ± 176.1

0.001 (−0.046–0.049)

0.957

143.6 ± 121.1

137.9 ± 113.9

−0.009 (−0.06–0.04)

0.730

CRP (mg/L)

1.08 ± 1.33

1.10 ± 1.67

0.75 ± 0.68

−0.12 (−0.11–0.08)

0.709

1.08 ± 1.33

1.08 ± 1.63

−0.01 (−0.11–0.09)

0.795

  1. CI confidence interval, M major allele, m minor allele
  2. aThe multiple linear regressions were adjusted for age, sex, BMI, current smoking status, and anti-hypertensive and anti-diabetic treatments